These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 16053129)

  • 1. Widening the window. Strategies to buy time in treating ischemic stroke.
    Delude CM
    Sci Am; 2005 Aug; 293(2):21-2. PubMed ID: 16053129
    [No Abstract]   [Full Text] [Related]  

  • 2. Stroke-MRI: extending the time-window: recent trials and clinical practice.
    Köhrmann M; Schellinger PD
    Int J Stroke; 2007 Feb; 2(1):53-4. PubMed ID: 18705990
    [No Abstract]   [Full Text] [Related]  

  • 3. [Intravenous administration of a tissue plasminogen activator beyond 3 hours of the onset of acute ischemic stroke--MRI-based decision making].
    Kakuda W; Abo M
    Brain Nerve; 2008 Oct; 60(10):1173-80. PubMed ID: 18975605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of MRI-based selection for recombinant tissue plasminogen activator treatment: responder analysis of outcome in the 3-hour time window.
    Sølling C; Hjort N; Ashkanian M; Østergaard L; Andersen G
    Cerebrovasc Dis; 2009; 27(3):223-9. PubMed ID: 19176954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can the therapeutic window for tissue plasminogen activator be extended to 6 hours after stroke onset?
    Alexandrov AV
    Nat Clin Pract Cardiovasc Med; 2005 Jul; 2(7):342-3. PubMed ID: 16265558
    [No Abstract]   [Full Text] [Related]  

  • 6. [Subjects in the acute thrombolytic therapy by intravenous administration of rt-PA].
    Suzuki A; Moroi J; Nakase T; Yoshioka S; Nagata K; Sato Y; Maeda T; Sawada M; Kobayashi N; Ogura N; Izumi M
    No To Shinkei; 2006 Nov; 58(11):931-6. PubMed ID: 17133998
    [No Abstract]   [Full Text] [Related]  

  • 7. Novel therapies for acute ischemic stroke.
    Leker RR; Eichel R; Rafaeli G; Ben-Hur T
    Isr Med Assoc J; 2006 Nov; 8(11):788-92. PubMed ID: 17180832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical, biochemical and neuroimaging parameters after thrombolytic therapy predict long-term stroke outcome.
    Brouns R; Sheorajpanday R; Kunnen J; De Surgeloose D; De Deyn PP
    Eur Neurol; 2009; 62(1):9-15. PubMed ID: 19407450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prospects of thrombolytic therapy for acute ischemic stroke].
    Nakashima T; Minematsu K
    Brain Nerve; 2009 Sep; 61(9):1003-12. PubMed ID: 19803399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete recanalization of right middle cerebral artery after intravenous thrombolytic therapy.
    Lo RY; Liu AB
    Acta Neurol Taiwan; 2005 Dec; 14(4):234-5. PubMed ID: 16425552
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of acute ischemic stroke: intravenous and endovascular therapies.
    Jahan R; Vinuela F
    Expert Rev Cardiovasc Ther; 2009 Apr; 7(4):375-87. PubMed ID: 19379062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obstacles to the use of intravenous tissue plasminogen activator for acute ischemic stroke. Is time the only barrier?
    Laloux P; Thijs V; Peeters A; Desfontaines P
    Acta Neurol Belg; 2007 Dec; 107(4):103-7. PubMed ID: 18416282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroimaging of ischemic stroke with CT and MRI: advancing towards physiology-based diagnosis and therapy.
    Hakimelahi R; González RG
    Expert Rev Cardiovasc Ther; 2009 Jan; 7(1):29-48. PubMed ID: 19105765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombolysis for concomitant acute stroke and pulmonary embolism.
    Allport LE; Butcher KS
    J Clin Neurosci; 2008 Aug; 15(8):917-20. PubMed ID: 18474426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombolysis 3 to 4.5 hours after acute ischemic stroke.
    Morris DC
    N Engl J Med; 2008 Dec; 359(26):2841; author reply 2841. PubMed ID: 19115492
    [No Abstract]   [Full Text] [Related]  

  • 16. Thrombolysis 3 to 4.5 hours after acute ischemic stroke.
    Schwamm LH; Fonarow GC
    N Engl J Med; 2008 Dec; 359(26):2840; author reply 2841. PubMed ID: 19115490
    [No Abstract]   [Full Text] [Related]  

  • 17. Spinal subdural hematoma following tissue plasminogen activator treatment for acute ischemic stroke.
    Kim SH; Choi SH; Song EC; Rha JH; Kim SR; Park HC
    J Neurol Sci; 2008 Oct; 273(1-2):139-41. PubMed ID: 18635196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful intravenous thrombolysis for acute stroke in a child.
    Ortiz GA; Koch S; Wallace DM; Lopez-Alberola R
    J Child Neurol; 2007 Jun; 22(6):749-52. PubMed ID: 17641263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous thrombolytic therapy for acute ischemic stroke: the experience of a community hospital.
    Hsu YC; Sung SF; Ong CT; Wu CS; Su YH
    Acta Neurol Taiwan; 2009 Mar; 18(1):14-20. PubMed ID: 19537569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multitargeted effects of statin-enhanced thrombolytic therapy for stroke with recombinant human tissue-type plasminogen activator in the rat.
    Zhang L; Zhang ZG; Ding GL; Jiang Q; Liu X; Meng H; Hozeska A; Zhang C; Li L; Morris D; Zhang RL; Lu M; Chopp M
    Circulation; 2005 Nov; 112(22):3486-94. PubMed ID: 16316970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.